CIK 0001842754
CELFX Cliffwater Enhanced Lending Fund
Insider trading from SEC Form 4. Last filing Mar 20, 2026. Close $10.73 on Oct 9, 2026, +7% from the 52-week low and -2% from the high.
Cliffwater Enhanced Lending Fund (CELFX) has 5 SEC Form 4 filings on file from 4 insiders, the latest filed on Mar 20, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
4 open-market trades have been scored at CELFX. The newest: Matthew Eugene Worley (director) bought $600k of stock on Mar 18, 2026, filed Mar 20, 2026, scored 42 (moderate). The largest of the 4 shown: Stephen Lane Nesbitt (President/Interested Trustee) bought $21M on May 7, 2025, scored 65 (notable).
CELFX closed at $10.73 on Oct 9, 2026, 7% above its 52-week low and 2% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Cliffwater Enhanced Lending Fund, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 42Moderate | Matthew Eugene Worley director buy | $600k 54,645 shares | - | +11% from low0% from high | |
| 63Notable | Stephen Lane Nesbitt President/Interested Trustee buy | $3.5M 321,691 shares | +9% | +9% from low0% from high | |
| 65Notable | Stephen Lane Nesbitt President/Interested Trustee buy | $21M 1,948,811 shares | +99% | +7% from low0% from high | |
| 41Moderate | Dominic Jerome Garcia director buy | $500k 45,413 shares | - | - |
Transactions
Every row filed, 6 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | Matthew Eugene Worley director | POpen-market purchase Class I Shares | +54,645 | $10.98 | $600k | 54,645 | Mar 20, 2026 |
| Aug 4, 2025 | Cliffwater LLC owner, other | JOther Class I Shares | -915 | $0.00 | $0 | 13,956 | Aug 6, 2025 |
| Aug 4, 2025 | Cliffwater LLC owner, other | JOther Class D Shares | +915 | $0.00 | $0 | 915 | Aug 6, 2025 |
| Jul 10, 2025 | Stephen Lane Nesbitt President/Interested Trustee | POpen-market purchase Class I Sharesindirect: See footnote | +321,691 | $10.88 | $3.5M | 3,883,883 | Jul 14, 2025 |
| May 7, 2025 | Stephen Lane Nesbitt President/Interested Trustee | POpen-market purchase Class I Sharesindirect: JN and BN 2023 Trust | +1,948,811 | $10.93 | $21M | 3,911,029 | May 9, 2025 |
| Nov 20, 2024 | Dominic Jerome Garcia director | POpen-market purchase Class I Shares | +45,413 | $11.01 | $500k | 45,413 | Nov 22, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Cliffwater LLCowner, other
- Dominic Jerome Garciadirector
- Stephen Lane NesbittPresident/Interested Trustee
- Matthew Eugene Worleydirector
Questions about CELFX
Answered from the filings on this page, as of the latest one.
Are insiders buying CELFX?
No. In the last 90 days no insider at Cliffwater Enhanced Lending Fund bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade CELFX on the open market?
Matthew Eugene Worley (director) bought $600k of CELFX on Mar 18, 2026 and filed the Form 4 on Mar 20, 2026. InsiderTell scored 42 (moderate).
How many insiders file Form 4 at Cliffwater Enhanced Lending Fund?
4 people have filed a Form 4 at Cliffwater Enhanced Lending Fund, among them Cliffwater LLC (10% owner), Dominic Jerome Garcia (director), Stephen Lane Nesbitt (President/Interested Trustee). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.